---
layout: post
title: "Definitions of Suspect Product and Illegitimate Product for Verification Obligations Under the Drug Supply Chain Security Act; Guidance for Industry; Availability"
date: 2026-02-05 18:35:55 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-05359
original_published: 2023-03-16 00:00:00 +0000
significance: 8.00
---

# Definitions of Suspect Product and Illegitimate Product for Verification Obligations Under the Drug Supply Chain Security Act; Guidance for Industry; Availability

**Published:** February 05, 2026 18:35 UTC
**Source:** Federal Register
**Original Published:** March 16, 2023 00:00 UTC
**Document Number:** 2023-05359

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Definitions of Suspect Product and Illegitimate Product for Verification Obligations Under the Drug Supply Chain Security Act." The guidance is intended to help industry better understand the definitions of "suspect" and "illegitimate" product as defined in the Drug Supply Chain Security Act (DSCSA). The guidance lays out FDA's current understanding of the following key terms used to define "suspect" and "illegitimate" product: "counterfeit," "diverted," "stolen," "fraudulent transaction," and "unfit for distribution." The guidance finalizes the draft guidance entitled "Definitions of Suspect Product and Illegitimate Product for Verification Obligations Under the Drug Supply Chain Security Act" issued on June 4, 2021.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/03/16/2023-05359/definitions-of-suspect-product-and-illegitimate-product-for-verification-obligations-under-the-drug)
- API: https://www.federalregister.gov/api/v1/documents/2023-05359

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
